Chapter CE Library

Below is a list of ready-to-go slide decks that Chapter Leaders can use for their Spring or Fall Learning Series. Once a chapter has presented a slide deck, they may not present it again.

---

2025

Pulmonary Hypertension: From Examination to Management (1.0 CE contact hours)

Learning Objectives

• Examine assessment, diagnosis and staging of Pulmonary Hypertension (PH)
• Explain the risks of vascular and right ventricular remodeling when PH is under-treated or untreated
• Compare and contrast the mechanism of actions of traditional and novel therapies for PH management
• Explore the role of the CV RN in a team-based care approach to PH management

Lipid Management in 2025 (1.0 CE contact hours)

Learning Objectives

• Identify at risk populations with inherited and non-inherited hyperlipidemias highlighting testing guidelines
• Summarize pharmacologic and non-pharmacologic approaches to lowering lipids
• Using case studies, identify the appropriate lipid-lowering agent for specific patient scenarios
• Discuss solutions to close the gap across social determinants of health in application of evidence-based lipid lowering guideline

2024

Hypertrophic Cardiomyopathy: Advances in Disease Management (1.0 CE contact hours)

Learning Objectives

• Review signs and symptoms of HCM to aid earlier recognition
• Explain the differential diagnosis process to rule out non-HCM causes of left ventricular hypertrophy
• Explore the role of novel cardiac myosin inhibitor drug class on HCM treatment
• Examine best practices from a high volume HCM center in access and adherence to novel treatment

Nurse Leaders: Successful Strategies and Tip to Help Along the Way (0.5 CE – 1.0 CE contact hours)

Learning Objectives

• Describe varying leadership styles applicable to nursing
• Discuss application of leadership strategies in nursing
• Explore the benefits and responsibilities of being a mentor and a mentee

Cardiac Amyloidosis: Increasing Awareness and Understanding (1.0 CE contact hours)

Learning Objectives

• Review the prevalence and prognosis of risk for cardiac amyloidosis in heart failure patients emphasizing early diagnosis for improved outcomes
• Discuss the distribution of and inequities in diagnosis and care for cardiac amyloidosis across patient populations including race, ethnicity and gender
• Examine the evolving signs and symptoms of cardiac amyloidosis subtypes (hereditary and wild type) as seen in diagnostic imaging including evidence-based treatments for each
• Explore the role of cardiovascular nurse in cardiac amyloidosis treatment and management highlighting promotion of shared-decision making to empower patients to play an active role in their care

Nurse Health and Well-Being (1.0 CE contact hours)

Learning Objectives

• Identify the physical health concerns found to be prominent in the nursing population.
• Review the impact of burnout, current workforce issues and stress on the mental health of nurses.
• Discuss occupational health safety including variations and methods to leverage employer wellness programs and workplace environment issues to promote healthy lifestyles and health attainment by nurse employees.
• Explore best practices and innovation in self-care and health promotion of the nursing workforce.

2023

Maternal Mortality & Cardiovascular Disease (1.0 CE contact hours)

Learning Objectives

• Describe cardiovascular and cardiometabolic complications of pregnancy including long term risks across the lifespan.
• Discuss the impact of social determinants of heath and implicit bias on cardiovascular related maternal mortality.
• Review current women’s health guidelines, policies and recommendations.
• Discuss best practices to prevent maternal mortality including improved hypertension monitoring, increased access to perinatal appointments, and more.

A Heart Healthy Lifestyle Counseling: A Focus on the Female Patient (1.0 CE contact hours)

Learning Objectives

• Identify two pregnancy complications associated with future CVD risk.
• Describe the integration of brief dietary counseling into a clinical visit.
• Apply evidence-based interventions to promote physical activity and healthy eating including the PCNA Heart Healthy Toolbox.

Hypertension: Current Guideline Recommendations (1.0 CE contact hours)

Learning Objectives

• Review current hypertension guidelines.
• Describe the association between high blood pressure and cardiovascular disease risk.
• Explain the impact of implicit bias, oppression and discrimination on cardiovascular health.
• Discuss treatment strategies for hypertension according to patient’s risk level, co-morbidities, race/ethnicity age.
• National Guidelines for the Primary Prevention of CVD: Integrating Hypertension, Cholesterol, Diabetes, and Lifestyle

Guidelines into Practice (1.5 CE contact hours)

Learning Objectives

• Cite and locate national guidelines related to CVD Risk Reduction.
• Understand the class or strength of treatment recommendations in guidelines.
• Explain how CV risk assessment tools and patient-centered approaches can help to individualize comprehensive management of CV risk.
• Apply current CVD prevention and risk reduction guidelines to patient care planning for lifestyle, physical activity, obesity, and tobacco use using a case study approach
• Describe application of current guideline recommendations for diabetes, cholesterol, hypertension, aspirin use, and more.

AFib in Clinical Practice: Recommended Tools and Treatments to Prevent Stroke (1.0 CE contact hours)

Learning Objectives

• Discuss the risk factors associated with undiagnosed and asymptomatic atrial fibrillation.
• Incorporate effective strategies for early detection of AFib into clinical practice
• Select tools that can help in communicating risk factors, prevention strategies, and treatment approaches with patients.
• Identify key aspects of current recommendations on atrial fibrillation, anticoagulation, stroke risk, and prevention approaches.

2022

Beyond Glycemic Control with SGLT2s and GLP1s RAs: New Evidence of Improved Cardiac, Renal, and Obesity Outcomes for Patients With and Without Diabetes (1.0 CE contact hours, 1.0 Pharmacology)

Learning Objectives

• Explain the role, function, and side effects of SGLT2 inhibitors and GLP1 receptor agonists.
• Review the current evidence of the cardio-protective effects of SGLT2is and GLP1 RAs including positive outcomes in heart failure treatment and arrythmia reduction.
• Discuss the weight loss benefit evidence of GLP1 RAs and SGLT2is in the picture of diabetic and nondiabetic patients.
• Summarize the renal benefits evidence for patients with T2D prescribed SGLT2is or GLP1 RAs.
• Explore interventions and tools to increase access and adherence to medication using a case study approach.

ASCVD Risk Estimation and Communication (1.0 CE contact hours)

Learning Objectives

• Describe modifiable and non-modifiable risk factors and enhancers that are known to increase the risk of atherosclerotic cardiovascular disease (ASCVD).
• Explain currently available ASCVD risk estimation tools.
• Apply tools that can predict risk for ASCVD across patient populations using a case study approach.
• Summarize Coronary Artery Calcium Scoring considerations.

The Basics of 12 Lead ECG Interpretation (1.0 CE contact hours)

Learning Objectives

• Explain which wall of the heart is being affected by abnormalities seen in 12-lead ECGs.
• Identify which coronary artery is being affected based on 12-Lead ECG findings.
• Discuss patient care considerations of specific ECG findings including electrolyte imbalances, Takotsubo Cardiomyopathy, QT prolongation, ventricular hypertrophy, atrial enlargement and bundle branch blocks.
• Apply knowledge of 12-lead interpretation techniques.

2020

Recommending Exercise in those with Obesity and Cardiovascular Risk Factors (1.0 CE contact hours)

Learning Objectives

• Describe the risk factors for cardiovascular disease and their association with overweight and obesity.
• Explain the steps in performing a Cardiovascular (CV) risk assessment for exercise clearance.
• Discuss counseling strategies for prescribing safe and effective exercise.

2019

Peripheral Arterial Disease: Risk Factors, Screening & Treatment (1.0 CE)

Learning Objectives

• Outline the risk factors associated with PAD.
• Describe the clinical presentation of patients with PAD.
• List the steps to perform an Ankle Brachial Index (ABI) to screen for PAD.
• Discuss common treatments for PAD including a supervised exercise training (SET) program for patients with claudication.

2018

Screening for Non-Valvular Atrial Fibrillation: Identifying the Undiagnosed Patient (1.0 CE)

Learning Objectives

• Review prevalence and common risk factors associated with non-valvular atrial fibrillation (NVAF).
• Describe typical signs and symptoms of NVAF and how to assess for them during a clinical encounter.
• Discuss the importance of pulse taking and follow up ECG to screen high risk patients for NVAF.
• Using case examples, illustrate how to initiate NVAF treatment, provide follow-up and collaboration across the continuum of care to ensure optimal patient outcomes.

Women’s Cardiovascular Care Across the Life Course – Promoting Prevention Among Women Who Experience Adverse Pregnancy Outcomes (1.0 CE)

Learning Objectives

• Identify key adverse pregnancy outcomes (APOs) that are associated with future cardiovascular or cardiometabolic risk.
• Identify persons who are at increased risk for developing these pregnancy-related complications.
• Describe the cardiovascular or cardiometabolic risk associated with these pregnancy-related complications.
• Describe clinical guidelines and recommendations for postpartum follow up and risk reduction.
• Apply evidence-based interventions to promote healthy eating, physical activity, and breastfeeding during the postpartum and childbearing years.